Search Results for citation:"86 FR 4105"

The National Institutes of Health, part of the U.S. Department of Health and Human Services, has announced an invention available for licensing. This invention is a high-throughput COVID-19 diagnostic test that uses next-generation sequencing to simultaneously detect the virus and the host's response. It aims to provide accurate and fast testing on a large scale, with potential applications in detecting various infectious organisms. The technology reduces reagent use and can also help predict the severity of the disease based on gene expression.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announced a closed meeting scheduled for February 17-18, 2021. The meeting is organized to review and evaluate grant applications and will be held via video at the National Institutes of Health in Bethesda, MD. The grant discussions will remain private to protect confidential information and personal privacy. For further information, individuals may contact Lan Tian, Ph.D., the Scientific Review Officer at NIDDK.

The National Institute on Alcohol Abuse and Alcoholism announced changes to the meeting schedule of the National Advisory Council on Alcohol Abuse and Alcoholism, originally set for February 4, 2021. The adjustments include new timing for the closed and open sessions, with the closed session now scheduled from 11:00 a.m. to 12:00 p.m., and the open session from 12:00 p.m. to 5:30 p.m. Part of the meeting will still be closed to the public. These changes were updated from the earlier notice published on December 21, 2020, in the Federal Register.